Search Results 81-90 of 16577 for Certolizumab

  1. A Study to Evaluate Clazakizumab in Patients with Life-threatening COVID-19 Infection (Enrolling by Invitation Only) - Mayo Clinic

    The primary purpose of this study is to assess the safety of clazakizumab treatment in COVID-19 infected patients with respiratory failure due to ...

  2. Adalimumab-atto (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Baricitinib; Certolizumab Pegol; Cholera Vaccine, Live; Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Etanercept; Golimumab ...

  3. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  4. A Study To Evaluate The Accuracy Of The Length-109 Probe Set Panel (A Genetic Test) In Predicting Response To Golimumab In Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    Participation eligibility · biologic therapy targeted at tumor necrosis factor alpha (eg, infliximab, adalimumab, golimumab, etanercept, certolizumab); ...

  5. Adalimumab-aaty (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Baricitinib; Certolizumab Pegol; Cholera Vaccine, Live; Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Etanercept; Golimumab ...

  6. Recurrent Cancer Clinical Trials - Mayo Clinic Research

    This phase Ib/II clinical trial studies the side effects and best dose of venetoclax and how well it works when given together with vincristine liposomal in ...

  7. A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments - Mayo Clinic

    This phase 1b trial is an open-label study designed to assess the safety, tolerability, and preliminary antitumor activity of REGN5458 in combination with other ...

  8. A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased Risk of Recurrence - Mayo Clinic

    ... certolizumab. Must undergo screening for HBV; Baseline CDAI < 200; Has adequate blood and liver test values. Exclusion Criteria. Has a history of latent or ...

  9. Infliximab-axxq (intravenous route) - Side effects & uses - Mayo Clinic

    Azathioprine; Bacillus of Calmette and Guerin Vaccine, Live; Baricitinib; Brodalumab; Certolizumab Pegol; Cholera Vaccine, Live; Cyclosporine; Dengue ...

  10. Clinical trials - Oncology (Medical)

    The use of this lotion is considered investigational since it hasn't been studied in lymphoma cancer patients with low magnesium levels before; however, the FDA ...